Angelini Pharma acquires ThermaCare® from GSK
![Slider Thermacare Newtest](/media/w3cfsmes/slider_thermacare_newtest.jpg?anchor=center&mode=crop&width=1030&height=302&rnd=132639066255400000&bgcolor=fff)
Angelini Pharma has acquired the ThermaCare® global business rights from GSK.
The European Commission has formally approved a deal for GSK to sell its rights for ThermaCare® Heat Wraps globally (excluding North America) to Angelini Pharma.
The deal also includes the dedicated US manufacturing site for ThermaCare in Albany (Georgia).